Biotricity, Inc.
BTCY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $3,886 | $3,874 | $3,703 | $3,619 |
| % Growth | 0.3% | 4.6% | 2.3% | – |
| Cost of Goods Sold | $704 | $757 | $724 | $855 |
| Gross Profit | $3,181 | $3,117 | $2,978 | $2,764 |
| % Margin | 81.9% | 80.5% | 80.4% | 76.4% |
| R&D Expenses | $603 | $696 | $573 | $551 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2,305 | $2,139 | $3,261 | $2,382 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2,908 | $2,835 | $3,834 | $2,933 |
| Operating Income | $274 | $282 | -$855 | -$169 |
| % Margin | 7% | 7.3% | -23.1% | -4.7% |
| Other Income/Exp. Net | -$965 | -$954 | -$1,080 | -$1,060 |
| Pre-Tax Income | -$691 | -$672 | -$1,936 | -$1,229 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$691 | -$672 | -$1,936 | -$1,229 |
| % Margin | -17.8% | -17.3% | -52.3% | -34% |
| EPS | -0.026 | -0.029 | -0.088 | -0.054 |
| % Growth | 8.4% | 67.5% | -62.5% | – |
| EPS Diluted | -0.026 | -0.029 | -0.088 | -0.054 |
| Weighted Avg Shares Out | 26,285 | 26,285 | 22,879 | 24,232 |
| Weighted Avg Shares Out Dil | 26,285 | 26,285 | 22,879 | 24,232 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $860 | $1,004 | $1,056 | $1,141 |
| Depreciation & Amortization | $202 | $1 | $1 | $1 |
| EBITDA | $372 | $333 | -$878 | -$87 |
| % Margin | 9.6% | 8.6% | -23.7% | -2.4% |